Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of XC8 in healthy volunteers
NCT02882217Phase 1Completed
- Sponsor
- EURRUS Biotech GmbH
- Start
- Aug 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of histamine glutarimide in asthma (4 arms), sponsored by EURRUS Biotech GmbH. Primary endpoints: Number of Adverse events per treatment arm, Laboratory data (hematology, biochemistry, urinalysis) at Day 15 and 2 more. Started Aug 2016; status: completed.
02
Drugs
histamine glutarimide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02882217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02882217.